SOX2 and Lung Cancer Stem Cells
Author Information
Author(s): Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang T S, Markowitz D, Reisfeld R A, Luo Y
Primary Institution: The Scripps Research Institute
Hypothesis
Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.
Conclusion
The study suggests that SOX2 plays a crucial role in maintaining cancer stem cell properties and that targeting SOX2 may be an effective strategy for lung cancer therapy.
Supporting Evidence
- D121-SP cells contain cancer stem cell characteristics.
- Downregulation of SOX2 significantly suppresses tumor growth.
- SOX2 knockdown increases apoptosis in D121-SP cells.
- SP cells show higher expression of stem cell markers compared to non-SP cells.
- SOX2 is involved in maintaining stem cell properties in lung cancer.
Takeaway
Scientists found that a protein called SOX2 helps cancer stem cells grow and spread in lung cancer, and reducing SOX2 can stop this.
Methodology
The study used flow cytometry and siRNA technology to analyze the effects of SOX2 knockdown on cancer stem cells in a mouse model.
Participant Demographics
C57BL/6 mice, 6–8 weeks of age.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website